$CBT

American Century entities (CBT) disclose over 5% ownership in Cabot Corporation

American Century ETF Trust and affiliated entities filed a Schedule 13G for Cabot Corporation common stock. American Century ETF Trust reported 2,640,178 shares, 5.1% of the class, with sole voting and dispositive power. American Century Investment Management, American Century Companies, and Stowers Institute reported 2,768,176 shares, 5.4%, also with sole power. No single advised client owns more than 5%.

Original reporting
Published Aug 14, 2026, 6:35 PM UTC
Analysis
alphai AI DeskAI-generated
Added to alphai Aug 14, 2026, 10:32 PM UTC. Informational, not investment advice.
How this was made
alphai summarizes source reporting and applies a structured AI analysis for relevance, timing, sentiment and ticker impact. Always verify material claims with the original publisher.
alphai market briefFinancial news
Primary signal
$CBT
Neutral
medium confidence
Mentioned
$CBT
Relevance
4/10
alphai data visualization · based on stocktitan.net
Decision brief

The 30-second read

$CBTNeutralLow
01

Why it matters

The key new information is the reported beneficial ownership level (5.1% and 5.4%) with sole voting and dispositive power for the reporting persons.

02

Market read

Ownership disclosures can influence positioning and monitoring, but this text contains no fundamental catalyst for Cabot.

03

What to watch

Traders may overreact to the 5% headline; the filing also states no single advised client exceeds 5%, which can reduce the likelihood of concentrated control behavior.

Relevance 4/10Novelty 6/10Timing: today’s SEC Schedule 13G disclosure (dated 06/30/2026)

Background

The article summarizes an SEC Schedule 13G beneficial ownership filing by American Century entities for Cabot Corporation common stock.

Company-level read

Ticker impact

$CBTNeutralMedium confidence
Context

American Century ETF Trust and affiliates disclosed beneficial ownership of Cabot Corporation common stock at 5.1% and 5.4% via SEC Schedule 13G.

Expected impact

Likely limited near-term price impact, but it can modestly shift sentiment and increase attention from other investors.

Evidence & confidence

The filing provides a fresh, concrete ownership datapoint (5.1% and 5.4%) but no accompanying operational, financial, or control change beyond beneficial ownership reporting.

Market effects

No direct sector read-through; this is company-specific ownership disclosure.

None indicated.

None indicated.

Counterpoint

A 13G above 5% does not necessarily imply activism or near-term strategic change, so the market may discount it.

Key entities

  • Cabot Corporation

    Subject of the Schedule 13G beneficial ownership disclosure.

  • American Century ETF Trust

    Reported 2,640,178 shares, 5.1% of the class, with sole voting and dispositive power.

  • American Century Investment Management, Inc.

    Reported 2,768,176 shares, 5.4% of the class, with sole voting and dispositive power.

  • American Century Companies, Inc.

    Also reported 2,768,176 shares, 5.4% of the class, with sole voting and dispositive power.

  • Stowers Institute for Medical Research

    Identified in the filing as part of the beneficial ownership group holding 2,768,176 shares, 5.4%.

Related articles

$CBTMedAI 8/10

Cabot’s New US$350 Million Bond Issue Might Change The Case For Investing In CBT

Cabot Corporation issued US$350 million in senior unsecured notes due 2029, altering its funding mix. The move may impact investor views on balance sheet flexibility, especially as earnings have softened. Q3 2026 results showed US$6 million net income on US$982 million sales, with full-year EPS guidance of US$2.77. The company projects US$4.0 billion revenue and US$479.7 million earnings by 2029.

$CBTMed

Cabot Corporation Q3 2026 Earnings Call Summary

Cabot Corp reported Q3 2026 results driven by a 19% year-over-year EBIT rise in Performance Chemicals. Reinforcement Materials saw lower gross profit per ton despite 5% higher volumes, tied to 2026 tire customer agreement headwinds. Adjusted EPS guidance for FY2026 was tightened to $6.15–$6.45, and Cabot plans a $125 million brownfield battery capacity expansion. CEO transition is planned.

$CBTMed

Cabot Corp (CBT) (Q3 2026) Earnings Call Highlights: Strong Performance Chemicals Growth

Cabot Corp (CBT) reported Q3 fiscal 2026 earnings call highlights, citing growth in Performance Chemicals and battery materials. Reinforcement Materials EBIT fell to $97 million from $128 million year over year, with a modest Q4 sequential decline expected. The company expects Performance Chemicals margins to normalize as raw material costs catch up to Q3 pricing. It updated its FY2026 tax rate to 28% to 30% and said it plans to resume buybacks in Q4.